公司简介

We are a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases in Asia.

主要成员

Stephen Lim、Lietao Li、Antonio Bertoletti

产品/服务

• 科技服务
• 药物基因组

TCR-T cell therapy

Identification of MHC Class I Viral Peptides Limited by Asian Populations.

New cancer immunotherapy

Drug candidates target Hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC).

融资信息

融资轮次	融资日期	投资方	融资额度
Series A	2018-05	Yashang Capital、Westlake Ventures Capital	$20M

关联公司